{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:50:31Z","timestamp":1723204231443},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12185-014-1652-5","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T07:45:04Z","timestamp":1407224704000},"page":"490-493","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell\/histiocyte-rich large B cell lymphoma"],"prefix":"10.1007","volume":"100","author":[{"given":"Akihito","family":"Fujimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kamihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kanisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisa","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"1652_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1987.tb02333.x","volume":"67","author":"U D\u00fchrsen","year":"1987","unstructured":"D\u00fchrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol. 1987;67:235\u20139.","journal-title":"Br J Haematol"},{"key":"1652_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10428199509059623","volume":"18","author":"K Gr\u00f8nbaek","year":"1995","unstructured":"Gr\u00f8nbaek K, D\u2019Amore F, Schmidt K. Autoimmune phenomena in non-Hodgkin\u2019s lymphoma. Leuk Lymphoma. 1995;18:311\u20136.","journal-title":"Leuk Lymphoma"},{"key":"1652_CR3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.21354","volume":"84","author":"M Hirokawa","year":"2009","unstructured":"Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, Watanabe T, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol. 2009;84:144\u20138.","journal-title":"Am J Hematol"},{"key":"1652_CR4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","volume":"48","author":"AW Hauswirth","year":"2007","unstructured":"Hauswirth AW, Skrabs C, Sch\u00fctzinger C, Gaiger A, Lechner K, J\u00e4ger U. Autoimmune hemolytic anemias, Evans\u2019 syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48:1139\u201349.","journal-title":"Leuk Lymphoma"},{"key":"1652_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0145-2126(90)90136-W","volume":"14","author":"R Alter","year":"1990","unstructured":"Alter R, Joshi SS, Verdirame JD, Weisenburger DD. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res. 1990;14:279\u201386.","journal-title":"Leuk Res"},{"key":"1652_CR6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02429.x","volume":"111","author":"P Fisch","year":"2000","unstructured":"Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol. 2000;111:1010\u201322.","journal-title":"Br J Haematol"},{"key":"1652_CR7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199901283400405","volume":"340","author":"R Handgretinger","year":"1999","unstructured":"Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med. 1999;340:278\u201384.","journal-title":"N Engl J Med"},{"key":"1652_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.12105","volume":"160","author":"A Hara","year":"2013","unstructured":"Hara A, Furuichi K, Higuchi M, Iwata Y, Sakai N, Kaneko S, et al. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. Br J Haematol. 2013;160:244\u201350.","journal-title":"Br J Haematol"},{"key":"1652_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ajh.21336","volume":"84","author":"T Kamesaki","year":"2009","unstructured":"Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am J Hematol. 2009;84:98\u2013101.","journal-title":"Am J Hematol."},{"key":"1652_CR10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 2007;92:1021\u20138.","journal-title":"Haematologica"},{"key":"1652_CR11","unstructured":"De Wolf-Peeters C, Delabie J, Campo E, Jaffe ES, Delsol G. T cell\/histiocyte-rich large B cell lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed.\u00a0Lyon: International Agency for Research on Cancer; 2008. p. 238\u20139."},{"key":"1652_CR12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000084450","volume":"113","author":"N Oyaizu","year":"2005","unstructured":"Oyaizu N, Kozai Y, Kodo H, Sunaga S, Iwabuchi K, Higashihara M, et al. A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich\/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes. Acta Haematol. 2005;113:194\u20137.","journal-title":"Acta Haematol"},{"key":"1652_CR13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/pbc.20974","volume":"47","author":"CM Bennett","year":"2006","unstructured":"Bennett CM, de Jong JL, Neufeld EJ. Targeted ITP strategies: do they elucidate the biology of ITP and related disorders? Pediatr Blood Cancer. 2006;47:706\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"1652_CR14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.seminhematol.2010.01.006","volume":"47","author":"RP Taylor","year":"2010","unstructured":"Taylor RP, Lindorfer MA. Antigenic modulation and rituximab resistance. Semin Hematol. 2010;47:124\u201332.","journal-title":"Semin Hematol"},{"key":"1652_CR15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12185-012-1206-7","volume":"96","author":"L \u010cervinek","year":"2012","unstructured":"\u010cervinek L, \u010cern\u00e1 O, \u010caniga M, Kon\u00ed\u0159ov\u00e1 E, Hlu\u0161\u00ed A, \u0160imkovi\u010d M, et al. Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. Int J Hematol. 2012;96:594\u20139.","journal-title":"Int J Hematol"},{"key":"1652_CR16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood-2007-07-101303","volume":"111","author":"C Dearden","year":"2008","unstructured":"Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, et al. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood. 2008;111:1820\u20136.","journal-title":"Blood"},{"key":"1652_CR17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/1042819021000055110","volume":"44","author":"E Jourdan","year":"2003","unstructured":"Jourdan E, Topart D, Richard B, Jourdan J, Sotto A. Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder. Leuk Lymphoma. 2003;44:889\u201390.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1652-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1652-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1652-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:11:21Z","timestamp":1559452281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1652-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,6]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1652"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1652-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,6]]}}}